Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

466 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Strategies That Delay Market Entry of Generic Drugs.
Vokinger KN, Kesselheim AS, Avorn J, Sarpatwari A. Vokinger KN, et al. Among authors: kesselheim as. JAMA Intern Med. 2017 Nov 1;177(11):1665-1669. doi: 10.1001/jamainternmed.2017.4650. JAMA Intern Med. 2017. PMID: 28975217
University-based science and biotechnology products: defining the boundaries of intellectual property.
Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2005 Feb 16;293(7):850-4. doi: 10.1001/jama.293.7.850. JAMA. 2005. PMID: 15713775
The swinging pendulum: the Supreme Court reverses course on ERISA and managed care.
Kesselheim AS, Brennan TA. Kesselheim AS, et al. Yale J Health Policy Law Ethics. 2005 Winter;5(1):451-63. Yale J Health Policy Law Ethics. 2005. PMID: 15742588 No abstract available.
Biomedical patents and the public's health: is there a role for eminent domain?
Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2006 Jan 25;295(4):434-7. doi: 10.1001/jama.295.4.434. JAMA. 2006. PMID: 16434634 No abstract available.
Will physician-level measures of clinical performance be used in medical malpractice litigation?
Kesselheim AS, Ferris TG, Studdert DM. Kesselheim AS, et al. JAMA. 2006 Apr 19;295(15):1831-4. doi: 10.1001/jama.295.15.1831. JAMA. 2006. PMID: 16622145 No abstract available.
The rise and fall of Natrecor for congestive heart failure: implications for drug policy.
Kesselheim AS, Fischer MA, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2006 Jul-Aug;25(4):1095-102. doi: 10.1377/hlthaff.25.4.1095. Health Aff (Millwood). 2006. PMID: 16835191
Medical-process patents--monopolizing the delivery of health care.
Kesselheim AS, Mello MM. Kesselheim AS, et al. N Engl J Med. 2006 Nov 9;355(19):2036-41. doi: 10.1056/NEJMhpr063626. N Engl J Med. 2006. PMID: 17093256 No abstract available.
Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending.
Kesselheim AS, Fischer MA, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2006 Nov-Dec;25(6):1637-47. doi: 10.1377/hlthaff.25.6.1637. Health Aff (Millwood). 2006. PMID: 17102189
The role of litigation in defining drug risks.
Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2007 Jan 17;297(3):308-11. doi: 10.1001/jama.297.3.308. JAMA. 2007. PMID: 17227983 No abstract available.
Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.
Kesselheim AS, Mello MM. Kesselheim AS, et al. Health Aff (Millwood). 2007 Mar-Apr;26(2):483-91. doi: 10.1377/hlthaff.26.2.483. Health Aff (Millwood). 2007. PMID: 17339677 Review.
466 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback